Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
about
The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs.Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells
P2860
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@en
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@nl
type
label
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@en
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@nl
prefLabel
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@en
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@nl
P2860
P50
P1476
Naphthoquinoxaline metabolite ...... fe drug in anticancer therapy.
@en
P2093
R A Carvalho
P2860
P2888
P304
P356
10.1007/S00204-016-1839-Z
P50
P577
2016-09-14T00:00:00Z